Search Results 221-230 of 30730 for Ovarian

1. Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Mayo Clinic

   The drug used for HIPEC will be carboplatin, a Food and Drug Administration (FDA) approved drug for use in ovarian, fallopian tube or primary peritoneal cancer.

2. A Study to Evaluate the Venn Ovarian CAncer Liquid Biopsy - Mayo Clinic

   ... Ovarian Cancer Liquid Biopsy among women with ovarian adnexal mass for which a surgery is planned. Participation eligibility. Participant eligibility ...

3. Living With Cancer: Ovarian cancer vaccine - Mayo Clinic News Network

   Ovarian cancer vaccines are a type of immunotherapy, which is treatment that harnesses the body's germ-fighting immune system to attack cancer cells.

4. Improving Genetic Referral Rates in Women with Ovarian Cancer - Mayo Clinic

   ... ovarian cancer at Mayo Clinic Rochester and to determine barriers to genetics counseling and testing from a patient perspective. Participation eligibility.

5. Development of PARP Inhibitors and DDR Modifiers To Treat Ovarian Cancer - Anticancer Drug Action Laboratory - Mayo Clinic Research

   ... ovarian cancer cells with deleterious BRCA1 or BRCA2 mutations. Building on these observations, Dr. Kaufmann's lab has been trying to understand the unique ...

6. Marion R. Curtis, Ph.D. - Mayo Clinic Faculty Profiles

   ... ovarian cancer. Significance to patient care. Despite the well-documented importance of immune infiltration in ovarian tumors to patient outcome, responses ...

7. Living With Cancer: Ovarian cancer risk after hysterectomy - Mayo Clinic News Network

   If you've had a hysterectomy, your risk of developing ovarian cancer or primary peritoneal cancer, a type of cancer that acts like ovarian cancer, ...

8. Cyclophosphamide and Vaccine Therapy in Treating Patients with Stage II-III Breast, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Mayo Clinic

   What researchers learn from this study could possibly be used in the future to prevent or delay recurrence of breast or ovarian cancers. Participation ...

9. Carboplatin and Gemcitabine Hydrochloride With or Without VX-970 in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Mayo Clinic

   Giving carboplatin and gemcitabine with or without ATR kinase inhibitor VX-970 may work better in treating ovarian, primary peritoneal, or fallopian tube cancer ...

10. A Phase Ib Study Of Cobimetinib Administered In Combination With Niraparib, With or Without Atezolizumab, To Patients With Advanced Platinum-Sensitive Ovarian Cancer - Mayo Clinic

    A Phase Ib Study Of Cobimetinib Administered In Combination With Niraparib, With or Without Atezolizumab, To Patients With Advanced Platinum-Sensitive Ovarian ...